论文部分内容阅读
目的探讨肺炎支原体感染和儿童哮喘的相关性,并有效的观察临床给予沙丁胺醇进行治疗的临床效果。方法采取金标快速检测法测定我院2009年2月到2010年2月之间收录的50例儿童哮喘患者(A组)和同期的50例肺炎患者(B组)的MP-IgM和MP-IgG特异性抗体的情况,A组在常规的治疗中给予沙丁胺醇进行治疗,B组在常规治疗中给予先锋类抗生素进行治疗,观察两组的临床治疗效果。结果通过两组的对比分析,A组患者的MP-IgM阳性率明显的高于B组的情况,差异有统计学意义(P<0.05);而两组的MP-IgG阳性率比较无明显的差异,统计学无意义(P>0.05);观察组的患者临床治疗总有效率明显的优于对照组的治疗总有效率,数据的比较具有明显的差异(P<0.05);结论临床中对于肺炎支原体感染和儿童哮喘的发生有着直接的联系,临床治疗的关键在于有效的控制与消除肺炎支原体的感染,采取沙丁胺醇进行治疗,具有较好的临床效果,值得临床中应用。
Objective To investigate the correlation between Mycoplasma pneumoniae infection and childhood asthma and to observe the clinical effect of salbutamol treatment. Methods Fifty children with asthma (group A) and 50 patients with pneumonia (group B) were enrolled in this study. The MP-IgM and MP- In the case of IgG-specific antibodies, group A was treated with salbutamol during routine treatment, and group B was treated with avant-garde antibiotics during routine treatment. The clinical effects of both groups were observed. Results By comparing the two groups, the positive rate of MP-IgM in group A was significantly higher than that in group B, the difference was statistically significant (P <0.05); while the positive rate of MP-IgG in group A was no significant difference (P> 0.05). The total effective rate of clinical treatment in observation group was significantly better than that of control group, with significant difference (P <0.05) .Conclusion The clinical efficacy of Mycoplasma pneumoniae infection and childhood asthma is directly linked to the clinical treatment of the key lies in effective control and elimination of Mycoplasma pneumoniae infection, to take salbutamol for treatment, has good clinical results, it is worth the clinical application.